CD86 and neoplasm: These three modules contained recognized immune-related genes, such as CD86 and CD226, which have been reported to increase the downstream activation of NF-κB (Rohr et al., 2016) and CXCL9 whose secretion recruited CD8+ T cells into the tumor bed (Han et al., 2021b).